DK1131087T4 - Lindring af prostatacancersymptomer - Google Patents

Lindring af prostatacancersymptomer

Info

Publication number
DK1131087T4
DK1131087T4 DK99958892T DK99958892T DK1131087T4 DK 1131087 T4 DK1131087 T4 DK 1131087T4 DK 99958892 T DK99958892 T DK 99958892T DK 99958892 T DK99958892 T DK 99958892T DK 1131087 T4 DK1131087 T4 DK 1131087T4
Authority
DK
Denmark
Prior art keywords
relief
bmp
prostate cancer
cancer symptoms
gdf
Prior art date
Application number
DK99958892T
Other languages
Danish (da)
English (en)
Other versions
DK1131087T3 (da
Inventor
Kuber T Sampath
Charles M Cohen
David C Rueger
Original Assignee
Stryker Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22704676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1131087(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stryker Corp filed Critical Stryker Corp
Publication of DK1131087T3 publication Critical patent/DK1131087T3/da
Application granted granted Critical
Publication of DK1131087T4 publication Critical patent/DK1131087T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
DK99958892T 1998-11-13 1999-11-12 Lindring af prostatacancersymptomer DK1131087T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19123998A 1998-11-13 1998-11-13
PCT/US1999/026636 WO2000029012A2 (fr) 1998-11-13 1999-11-12 Procedes servant a soulager les symptomes du cancer

Publications (2)

Publication Number Publication Date
DK1131087T3 DK1131087T3 (da) 2004-12-13
DK1131087T4 true DK1131087T4 (da) 2009-08-03

Family

ID=22704676

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99958892T DK1131087T4 (da) 1998-11-13 1999-11-12 Lindring af prostatacancersymptomer

Country Status (10)

Country Link
EP (2) EP1131087B2 (fr)
JP (2) JP4892131B2 (fr)
AT (1) ATE275416T1 (fr)
AU (1) AU1616700A (fr)
CA (1) CA2349038C (fr)
DE (1) DE69920033T3 (fr)
DK (1) DK1131087T4 (fr)
ES (1) ES2226467T5 (fr)
PT (1) PT1131087E (fr)
WO (1) WO2000029012A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026713A1 (de) * 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
NZ573742A (en) * 2001-09-18 2010-07-30 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor, particularly breast tumor - TAT212
CA2561809A1 (fr) * 2004-03-31 2005-10-20 Xencor, Inc. Variants de bmp-7 ayant des proprietes ameliorees
EP1781814B3 (fr) * 2004-08-10 2011-08-31 Cardiff Biologicals Limited Procedes et trousse pour le pronostic du cancer du sein
EP1802326A2 (fr) * 2004-09-09 2007-07-04 Stryker Corporation Methodes de traitement de tumeurs osseuses
JP2008169116A (ja) * 2005-04-18 2008-07-24 Tokyo Medical & Dental Univ Ｂｍｐ−７を含む抗ｃ型肝炎ウイルス剤
EP1885750B1 (fr) 2005-05-27 2011-08-17 BBS - Bioactive Bone Substitutes Oy Protéine morphogénétique d'os 4 et dispositifs ostéogéniques et produits pharmaceutiques les contenant
ATE533781T1 (de) 2005-05-27 2011-12-15 Bbs Bioactive Bone Substitutes Oy Heparin-bindungsstelle enthaltendes knochenmorphogenetisches protein 6 und osteogene vorrichtungen und pharmazeutische produkte, die diese enthalten
ES2642591T3 (es) 2005-05-27 2017-11-16 Bbs-Bioactive Bone Substitutes Oy Proteína morfogenética ósea 3 y dispositivos osteogénicos y productos farmacéuticos que contienen la misma
US9220756B2 (en) * 2005-07-19 2015-12-29 Stemgen S.P.A. Inhibition of the tumorigenic potential of tumor stem cells by LIF and BMPS
GB0615129D0 (en) * 2006-07-29 2006-09-06 Univ Cardiff Anti-cancer activity of BMP-9 and BMP-10 and their use in cancer therapies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739107A (en) * 1991-03-11 1998-04-14 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
DK0575555T3 (da) † 1991-03-11 2001-11-05 Curis Inc Proteininduceret morfogenese
US5652118A (en) † 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
US6287816B1 (en) * 1991-06-25 2001-09-11 Genetics Institute, Inc. BMP-9 compositions
JP4344012B2 (ja) † 1992-07-31 2009-10-14 ストライカー・コーポレーション 組織形成因子誘導による神経の再生と修復
CA2144515A1 (fr) * 1992-09-15 1994-03-31 Charles M. Cohen Traitement des ulceres gastro-intestinaux
ATE378407T1 (de) † 1994-04-29 2007-11-15 Curis Inc Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen
JPH08225454A (ja) * 1995-02-23 1996-09-03 Chugai Pharmaceut Co Ltd マイクロスフェア製剤
FR2737501B1 (fr) * 1995-07-31 1997-10-24 Transgene Sa Nouveaux virus auxiliaires pour la preparation de vecteurs viraux recombinants
AU7115996A (en) † 1995-09-21 1997-04-09 Trustees Of Columbia University In The City Of New York, The Uses of bone morphogenetic proteins
AU7473098A (en) * 1997-05-07 1998-11-27 Biogen, Inc. Novel therapies for cystic kidney disease

Also Published As

Publication number Publication date
ATE275416T1 (de) 2004-09-15
DK1131087T3 (da) 2004-12-13
ES2226467T3 (es) 2005-03-16
PT1131087E (pt) 2004-12-31
EP1435243A3 (fr) 2005-02-09
JP2002529513A (ja) 2002-09-10
JP2010150278A (ja) 2010-07-08
ES2226467T5 (es) 2009-08-27
AU1616700A (en) 2000-06-05
WO2000029012A3 (fr) 2000-11-16
CA2349038C (fr) 2011-08-02
EP1131087A2 (fr) 2001-09-12
WO2000029012A2 (fr) 2000-05-25
DE69920033T3 (de) 2009-10-08
JP4892131B2 (ja) 2012-03-07
DE69920033T2 (de) 2005-09-22
EP1131087B2 (fr) 2009-04-01
EP1435243A2 (fr) 2004-07-07
DE69920033D1 (de) 2004-10-14
WO2000029012A8 (fr) 2001-01-11
CA2349038A1 (fr) 2000-05-25
EP1131087B1 (fr) 2004-09-08

Similar Documents

Publication Publication Date Title
Moan et al. The biophysical foundations of photodynamic therapy
DK1131087T4 (da) Lindring af prostatacancersymptomer
SE9900100D0 (sv) New compounds
CA2170700A1 (fr) Pyrazolopyrimidines et pyrrolopyrimidines pour le traitement des troubles neuronaux ou autres
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
AU6613896A (en) Chemical compounds
JP2000503980A5 (fr)
ATE282313T1 (de) ANTITUBULINANORDNUNG UND ZELLENWACHSTUMSHEMMSTOFF ßDIOXOSTATINß
WO2001098279A3 (fr) Bis-arylsulfones
WO2000018439A3 (fr) Utilisation de marqueurs de neoangiogenese pour diagnostiquer et traiter des tumeurs
CA2450787A1 (fr) Combinaison d'ingredients actifs pour substance pharmacologique toxicomanogene ou therapie contre les substances intoxicantes
DE60128100D1 (de) Analgetisches arzneimittel
NO20032762L (no) Aktivitetsstyringsanordning
BR0012553A (pt) Pastilhas contendo ambroxol
ITRM940149A0 (it) Dispositivo per volatilizzare nell'aria un ingrediente attivo, mediante combustione incompleta.
TR199901017A2 (xx) B�cek ilac� terkibi.
AP9400647A0 (en) Medicaments for use in treatment of HIV or cancer patients.
WO2002099422A3 (fr) Personnalisation de therapie avec des agents de la maladie d'alzheimer
AU2001291133A1 (en) Methods of decreasing or preventing pain using spicamycin derivatives
CA2153778A1 (fr) Methode d'utilisation de polynucleotides, d'oligonucleotides et de leurs derives pour traiter divers etats maladifs
Coppola et al. Early retroduodenal perforation following endoscopic internal biliary drainage
DE69625210D1 (de) Nicorandil gegen angstneurosen
IT1302188B1 (it) Procedimento e dispositivo atti alla regolazione di una grandezzadi funzionamento di un veicolo.
TR200103219T2 (tr) Nöropatik ağrının iyileştirilmesinde kullanım için aroil aminoasil piroller
CA2452432A1 (fr) Combinaison d'ingredients actifs de pharmacotherapie contre la dependance a la nicotine